Your Messages Inbox
Your Article Summary
See Latest ArticlesAPP Pharmaceutical Supports New USP Standards for Unfractionated Heparin
American Pharmaceutical Partners, 10/02/09
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., and the leading supplier of heparin sodium to the U.S. market, announced its continued support of the US Food & Drug Administration and medical community for the October 2009 implementation of the new United States Pharmacopeia monograph change for unfractionated heparin. The purpose of the USP monograph changes are to further assure the purity of the Active Pharmaceutical Ingredient through specific assay tests and calibrate activity to align with the International Standard issued by the World Health Organization.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09
Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09
Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Retigabine Regulatory Update
GlaxoSmithKline, 11/03/09
Review calls for EHR action in Saskatchewan
Canadian Healthcare Technology, 11/20/09
New Drug Application Filed for Eldecalcitol, An Active Vitamin D3 Derivative
Chugai Pharmaceutical Co., 11/04/09
Article Search
Sponsor